Navigation Links
Poniard Pharmaceuticals Announces Upcoming Conference Participation
Date:8/27/2008

SOUTH SAN FRANCISCO, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will participate in three upcoming conferences in September during which he will provide a corporate overview, including a discussion of the clinical development program for picoplatin, the Company's lead product candidate.

-- The Thomas Weisel Partners Healthcare Conference on Wednesday, September 3, at 4:25 p.m. Eastern Time at the Four Seasons Hotel in Boston

-- BioCentury's NewsMakers in the Biotech Industry Conference on Thursday, September 4, at 2:30 p.m. Eastern Time at the Millennium Broadway Hotel in New York

-- The 3rd Annual Citi Biotech Day on Monday, September 8, at 2:35 p.m. Eastern Time at the Citi Center in New York

Live audio webcasts of Poniard's presentations at the Thomas Weisel Partners Healthcare Conference and Citi Biotech Day will be available for 10 business days following each conference. Each webcast can be accessed on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors,
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Poniard Pharmaceuticals Announces Upcoming Conference Participation
6. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
7. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
8. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
9. Poniard Pharmaceuticals Announces Upcoming Conference Participation
10. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
11. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Pfenex Inc. (NYSE MKT: PFNX), ... high-value and difficult to manufacture proteins including biosimilar therapeutics, ... 21 st Annual NewsMakers in the Biotech Industry ... Bertrand Liang , chief executive officer of Pfenex, will ... business strategy on Friday, September 26, 2014 at 10:00 ...
(Date:9/19/2014)... 19, 2014 ... ) has announced the addition of the  "Micro ... to their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... of the fastest-growing segments in the chromatography market. ... 2013, and expected to reach $2.0 billion by ...
(Date:9/18/2014)... Austin, TX (PRWEB) September 18, 2014 ... of integrated urological and interventional radiology products and ... (also known as cryotherapy and cryoablation) versus external ... Mid-Atlantic Section of the American Urological Association (MAAUA) ... , "Comparing Relative Effectiveness of Cryosurgery and ...
(Date:9/18/2014)... KEEGO HARBOR, Mich. , Sept. 18, 2014  Health ... -based biotech firm investigating early-stage algae bioactive compounds and metabolic ... member to the company,s board of directors. Ms. Nola ... executive and investment advisor joined the board effective September 17, ... have Ms. Masterson agree to join our board," states ...
Breaking Biology Technology:Pfenex to Present at Upcoming Industry Conference on September 26 2Micro Market Monitor : Global Pre-packed Chromatography Columns 2HealthTronics Announces Data Comparing Cryotherapy Versus Radiation for Treating Prostate Cancer Poster Presented at the American Urological Association Regional Meeting 2Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2
... Oct. 13 This afternoon, Fraunhofer USA, Inc.,s ... its first laboratory, a PV module innovation facility ... Ambassador Klaus Scharioth and Massachusetts Energy Secretary Bowles. ... , The new PV module laboratory enables research, ...
... and MIAMI, Oct. 13 The Alpha-1 Foundation announced ... study how genetic variations in the alpha-1 antitrypsin (AAT) ... with AAT deficiency. The inherited condition causes emphysema and ... infusion therapy -- known as augmentation therapy -- minimizes ...
... 13 Advanced Life Sciences Holdings, Inc. (OTC ... the discovery, development and commercialization of novel drugs ... respiratory diseases, today announced that it will present ... in San Francisco. , (Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO ...
Cached Biology Technology:Fraunhofer CSE Opens First Laboratory in Cambridge, MA 2Fraunhofer CSE Opens First Laboratory in Cambridge, MA 3The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 2The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 3The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 4Advanced Life Sciences to Present at 8th Annual BIO Investor Forum 2
(Date:9/18/2014)... Elsevier, a world-leading provider of scientific, technical ... Australasian Research Management Society (ARMS), recognized the academic ... 5th Scopus Young Researcher of the Year Awards. ... the National Convention Centre and in conjunction with ... guests representing Australia,s and New Zealand,s scientific community. ...
(Date:9/18/2014)... world, are the ideal animal in which to study ... the ocean into tens of thousands of freshwater streams ... skeleton to adapt to the new environment. , Breeding ... have turned up one of the genes that controls ... that gene,s regulation in a freshwater population is associated ...
(Date:9/18/2014)... swim up to 400 kilometres in search of a home, ... , Clownfish spend their entire adult lives under the protection ... the open ocean, says study co-author, Dr Hugo Harrison from ... CoE) at James Cook University. , "In the past we ... a rare glimpse into how far they can swim, crossing ...
Breaking Biology News(10 mins):Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3Nemo's epic journey to find a new home 2
... over global warming and instead reduce fossil-fuel use for the ... scientists, one from the University of Washington and one from ... in the current issue of the journal Nature ... supply will trump the environment as a reason to curb ...
... Irvine, Calif., Jan. 26, 2012 Location matters for ... UC Irvine and Wesleyan University. Findings suggest that chickadees and ... as the characteristics of their wriggly prey. Unfortunately for ... can dramatically boost their own risk of becoming food. Study ...
... for breast cancer research as well as basic cell ... Lawrence Berkeley National Laboratory (Berkeley Lab) have discovered a ... ability of breast cells to form the spherical structures ... which the researchers call "CAMo," for coherent angular motion, ...
Cached Biology News:Commentary in Nature: Can economy bear what oil prices have in store? 2Commentary in Nature: Can economy bear what oil prices have in store? 3For the birds 2Berkeley Lab researchers discover critical rotational motion in cells 2Berkeley Lab researchers discover critical rotational motion in cells 3Berkeley Lab researchers discover critical rotational motion in cells 4
Request Info...
... (YELLOW), 1 EA. Ultrospec 6300 ... requirements of the Pharmacopoeia in terms of ... benefits of being able to be used ... nm and excellent scanning capability., *Press to ...
... Labeling Kit, 1 kit. Convenient ... dyes. Conjugations are carried out under ... h. Dyes are packaged in premeasured ... labelings. Category: Blotting & Labeling & ...
nucleophosmin (nucleolar phosphoprotein B23, numatrin), mRNA...
Biology Products: